September 20, 2019- August 16, 2019
- August 6, 2019Burlingame, Calif., August 6, 2019 — Inflammatix, a molecular diagnostics company that is reimagining diagnostics, announced today that it has received the…
- August 6, 2019
- May 16, 2019Burlingame, Calif., May 16, 2019 — Inflammatix announced today that it has been named a finalist for the American Association for Clinical Chemistry’s (AACC)…
- February 13, 2019
- October 28, 2018
- October 4, 2018Burlingame, Calif., October 4, 2018 — Inflammatix today announced that it will present findings from two studies demonstrating the ability of its HostDx™…
- April 17, 2018
